260 related articles for article (PubMed ID: 26511922)
41. Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression.
Feng HH; Zhu ZX; Cao WJ; Yang F; Zhang XL; Du XL; Zhang KS; Liu XT; Zheng HX
Cell Death Dis; 2018 Aug; 9(9):885. PubMed ID: 30158514
[TBL] [Abstract][Full Text] [Related]
42. Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements.
Gao Y; Sun SQ; Guo HC
Virol J; 2016 Jun; 13():107. PubMed ID: 27334704
[TBL] [Abstract][Full Text] [Related]
43. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions.
Summerfield A; Guzylack-Piriou L; Harwood L; McCullough KC
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):205-10. PubMed ID: 19026453
[TBL] [Abstract][Full Text] [Related]
44. Foot-and-mouth disease virus leader proteinase: specificity at the P2 and P3 positions and comparison with other papain-like enzymes.
Kuehnel E; Cencic R; Foeger N; Skern T
Biochemistry; 2004 Sep; 43(36):11482-90. PubMed ID: 15350134
[TBL] [Abstract][Full Text] [Related]
45. Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections.
Rai DK; Lawrence P; Kloc A; Schafer E; Rieder E
Virol J; 2015 Dec; 12():224. PubMed ID: 26695943
[TBL] [Abstract][Full Text] [Related]
46. Expression of porcine Mx1 with FMDV IRES enhances the antiviral activity against foot-and-mouth disease virus in PK-15 cells.
Yuan B; Fang H; Shen C; Zheng C
Arch Virol; 2015 Aug; 160(8):1989-99. PubMed ID: 26047650
[TBL] [Abstract][Full Text] [Related]
47. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection.
de Los Santos T; Diaz-San Segundo F; Grubman MJ
J Virol; 2007 Dec; 81(23):12803-15. PubMed ID: 17881445
[TBL] [Abstract][Full Text] [Related]
48. Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus.
Zhu J; Weiss M; Grubman MJ; de los Santos T
Virology; 2010 Aug; 404(1):32-40. PubMed ID: 20494391
[TBL] [Abstract][Full Text] [Related]
49. Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.
Borrego B; Rodríguez-Pulido M; Revilla C; Álvarez B; Sobrino F; Domínguez J; Sáiz M
Viruses; 2015 Jul; 7(7):3954-73. PubMed ID: 26193305
[TBL] [Abstract][Full Text] [Related]
50. Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infection.
Arzt J; Pacheco JM; Smoliga GR; Tucker MT; Bishop E; Pauszek SJ; Hartwig EJ; de los Santos T; Rodriguez LL
Virology; 2014 Mar; 452-453():12-22. PubMed ID: 24606678
[TBL] [Abstract][Full Text] [Related]
51. Comparative Proteomic Analysis of Wild-Type and SAP Domain Mutant Foot-and-Mouth Disease Virus-Infected Porcine Cells Identifies the Ubiquitin-Activating Enzyme UBE1 Required for Virus Replication.
Zhu Z; Yang F; Zhang K; Cao W; Jin Y; Wang G; Mao R; Li D; Guo J; Liu X; Zheng H
J Proteome Res; 2015 Oct; 14(10):4194-206. PubMed ID: 26354183
[TBL] [Abstract][Full Text] [Related]
52. Molecular phylogeny of leader proteinase gene of type A of Foot-and-mouth disease virus from India.
Tosh C; Mittal M; Sanyal A; Hemadri D; Bandyopadhyay SK
Arch Virol; 2004 Mar; 149(3):523-36. PubMed ID: 14991441
[TBL] [Abstract][Full Text] [Related]
53. Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo.
Xu J; Qian P; Wu Q; Liu S; Fan W; Zhang K; Wang R; Zhang H; Chen H; Li X
Antiviral Res; 2014 Sep; 109():22-9. PubMed ID: 24973762
[TBL] [Abstract][Full Text] [Related]
54. Production of foot-and-mouth disease virus capsid proteins by the TEV protease.
Puckette M; Smith JD; Gabbert L; Schutta C; Barrera J; Clark BA; Neilan JG; Rasmussen M
J Biotechnol; 2018 Jun; 275():7-12. PubMed ID: 29581033
[TBL] [Abstract][Full Text] [Related]
55. Esterase D enhances type I interferon signal transduction to suppress foot-and-mouth disease virus replication.
Li W; Zhu Z; Cao W; Yang F; Zhang X; Li D; Zhang K; Li P; Mao R; Liu X; Zheng H
Mol Immunol; 2016 Jul; 75():112-21. PubMed ID: 27267271
[TBL] [Abstract][Full Text] [Related]
56. Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.
Golde WT; de Los Santos T; Robinson L; Grubman MJ; Sevilla N; Summerfield A; Charleston B
Transbound Emerg Dis; 2011 Aug; 58(4):283-90. PubMed ID: 21501424
[TBL] [Abstract][Full Text] [Related]
57. The binding of foot-and-mouth disease virus leader proteinase to eIF4GI involves conserved ionic interactions.
Foeger N; Kuehnel E; Cencic R; Skern T
FEBS J; 2005 May; 272(10):2602-11. PubMed ID: 15885108
[TBL] [Abstract][Full Text] [Related]
58. Foot-and-mouth disease virus leader proteinase: a papain-like enzyme requiring an acidic environment in the active site.
Kronovetr J; Skern T
FEBS Lett; 2002 Sep; 528(1-3):58-62. PubMed ID: 12297280
[TBL] [Abstract][Full Text] [Related]
59. L protease from foot and mouth disease virus confers eIF2-independent translation for mRNAs bearing picornavirus IRES.
Moral-López P; Alvarez E; Redondo N; Skern T; Carrasco L
FEBS Lett; 2014 Nov; 588(21):4053-9. PubMed ID: 25268112
[TBL] [Abstract][Full Text] [Related]
60. Hydrolytic properties and substrate specificity of the foot-and-mouth disease leader protease.
Santos JA; Gouvea IE; Júdice WA; Izidoro MA; Alves FM; Melo RL; Juliano MA; Skern T; Juliano L
Biochemistry; 2009 Aug; 48(33):7948-58. PubMed ID: 19580333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
